Indazoles

US8846935B2 · kind B2 · utility

Assignee

• GlaxoSmithKline LLC · US

Inventors

• Celine Duquenne · Collegeville, US
• Neil W. Johnson · Collegeville, US
• Steven David Knight · West Chester, US
• Louis Lafrance · Collegeville, US
• William Henry Miller · Collegeville, US
• Kenneth A. Newlander · West Chester, US
• Stuart Paul Romeril · Collegeville, US
• Meagan B. Rouse · Collegeville, US
• Xinrong Tian · Collegeville, US
• Sharad Kumar Verma · New Haven, US

Key dates

• Filing date: May 5, 2011
• Grant date: Sep 30, 2014
• Expiry date: Jun 23, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Herein are disclosed indazoles of formula (I)where the various groups are defined herein, and which are useful for treating cancer.